BMC Cardiovascular Disorders

Table 2 Cardiovascular risk factors at baseline and follow-up in patients with the metabolic syndrome¹

From: Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary care

		Baseline			8 weeks			Difference²
		N	mean	± SD	N	mean	± SD	N	mean	± SD
Blood pressure
systolic	mmHg	1319	160.0	13.8	1312	133.3	10.4	1289	-26.6*	14.3
diastolic	mmHg	1319	94.6	8.6	1312	80.9	6.5	1289	-13.6*	9.2
Fasting plasma glucose
	mg/dL	1234	95.5	17.9	769	92.9	14.9	764	-2.5*	13.1
Waist circumference
men	cm	634	107.2	11.7	599	106.1	11.8	598	-1.1*	4.1
women	cm	530	97.3	13.0	498	96.7	13.3	496	-0.7*	3.5
Triglycerides
	mg/dL	1186	205.0	91.3	753	185.0	74.4	741	-19.1*	61.0
HDL Cholesterol
men	mg/dL	635	46.9	17.4	395	47.6	13.3	384	1.1*	11.0
women	mg/dL	526	51.3	16.6	338	53.2	15.6	331	2.3*	10.8

¹ defined by the AHA/NHLBI 2004 [17]; ² difference versus baseline; statistical test applied: t-test; * p < 0.0001. Adjusted for age.

Back to article page

ISSN: 1471-2261

Contact us

Submission enquiries: bmccardiovasculardisorders@biomedcentral.com
General enquiries: ORSupport@springernature.com